Skip to the main content.
Facebook Linkedin X

GETTING TO THE CLINIC  MATTERS 

 

For 30+ years, KBI Biopharma has been driven by a single mission: helping innovators deliver therapies to patients sooner.

KBI’s cell line development (CLD) rebate program helps you reduce financial pressure as your programs move from cell line development to GMP.

 

Receive a credit of up to $500,000 applied to the proposal for your first GMP batch.

 

Don't Let Progress Stall You.
Let It Reward You.
 

 

Sign Up for Limited Slots 

A Better Way from CLD to GMP 

The CLD Rebate Program helps relieve financial pressure at a critical transition point.  
Our goal is simple: support progress, strengthen continuity, and help promising programs move forward.

190
+

Clinical Programs

450
+

INDs

(15+ Annual Supported)

13

Commercial Products

30
+

Years of Experience Bringing Therapeutics to Clinic

Unmatched Speed Meets Financial Efficiency

Mitigated Manufacturing Costs

 

We offset clinical manufacturing expenses by matching your CLD spend up to $500k.

Compressed Timelines

 

Keeping CLD and GMP manufacturing under a single provider eliminates tech transfer friction and timeline delays.

Selexis® Reliability

 

Build your program on high-expressing, stable cell lines recognized by regulatory bodies for smooth clinical entry.

How the CLD Rebate Program Works

 

Step 1: Develop your high-yielding cell line using Selexis technology.


Step 2: Advance into your first GMP batch with KBI. 


Step 3: Receive a credit of up to $500,000 applied to the proposal for
your first GMP batch.

Terms & Conditions 

  • The credit is applied directly to the proposal for your first GMP batch.
  • The credit matches the amount spent on CLD work, up to a maximum of $500,000.
  • The first GMP batch must use Selexis-derived cell line created during the CLD phase of the project.
  • Only applicable to new CLD programs. Cannot retroactively apply.
  • KBI reserves the right to end the CLD rebate program due to limited availability.

Connect With a CLD Specialist

Fill out the form below to speak with one of KBI Biopharma's cell line development experts to discuss your
program.

Flexible, Knowledgeable, and Proven


About KBI Biopharma

KBI Biopharma is a leading global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. With each of our 1400+ customer partners, we work closely to personalize and accelerate drug development programs. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, we deliver robust process development and clinical and commercial cGMP manufacturing services for mammalian and microbial. Recognized for quality manufacturing, we help clients advance drug candidates into the clinic and beyond.

Science Driven. Customer Focused.